Finally, although there was no significant difference in the levels of CD4+ Th22 cell subset in people with PCC in comparison with participants with acute forms of COVID-19, the highest proportion of individuals in which Th22 cells showed no capacity to express IL-13 or IL-22 in response to stimuli were those in the PCC cohort. The gene discussed is CD4; the disease is COVID-19.